A consideration of CYP2D6 genetic variations in the Ghanaian population as a potential ‘culprit’ for the tramadol ‘abuse crisis’
Abstract Background Cytochrome P450 2D6 is involved in the metabolism of several important medicines including opioids. Variations in CYP2D6 have been implicated in drug response and according to the Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, dosing for CYP2D6 s...
Main Authors: | Nicholas Ekow Thomford, Susanna Aba Abraham, Samuel Badu Nyarko, Robert Peter Biney |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-01-01
|
Series: | BMC Medical Genomics |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12920-023-01773-8 |
Similar Items
-
Evaluation of Pupillometry for CYP2D6 Phenotyping in Children Treated with Tramadol
by: Frédérique Rodieux, et al.
Published: (2023-08-01) -
Evaluation of antinociceptive and analgesic properties of tramadol in cats
by: Basiri, Bita
Published: (2013) -
An Investigation of O-Demethyl Tramadol/Tramadol Ratio for Cytochrome P450 2D6 Phenotyping: The CYTRAM Study
by: Blandine De La Gastine, et al.
Published: (2022-10-01) -
Crizotinib inhibits the metabolism of tramadol by non-competitive suppressing the activities of CYP2D1 and CYP3A2
by: Nanyong Gao, et al.
Published: (2024-05-01) -
Efficacy of submucosal administration of tramadol on acute pain following third molar surgery: a systematic review and meta-analysis
by: Ahmad Salem Assari, et al.
Published: (2024-11-01)